157 related articles for article (PubMed ID: 24345702)
1. Immunotherapeutic potential of recombinant ESAT-6 protein in mouse model of experimental tuberculosis.
Mir SA; Verma I; Sharma S
Immunol Lett; 2014; 158(1-2):88-94. PubMed ID: 24345702
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapeutic potential of N-formylated peptides of ESAT-6 and glutamine synthetase in experimental tuberculosis.
Mir SA; Sharma S
Int Immunopharmacol; 2014 Feb; 18(2):298-303. PubMed ID: 24369314
[TBL] [Abstract][Full Text] [Related]
3. Adjunct immunotherapy with Ag85 complex proteins based subunit vaccine in a murine model of Mycobacterium tuberculosis infection.
Giri PK; Verma I; Khuller GK
Immunotherapy; 2009 Jan; 1(1):31-7. PubMed ID: 20635971
[TBL] [Abstract][Full Text] [Related]
4. Cloning, expression, and immunogenicity of novel fusion protein of Mycobacterium tuberculosis based on ESAT-6 and truncated C-terminal fragment of HSP70.
Tebianian M; Hoseini AZ; Ebrahimi SM; Memarnejadian A; Mokarram AR; Mahdavi M; Sohrabi N; Taghizadeh M
Biologicals; 2011 May; 39(3):143-8. PubMed ID: 21388826
[TBL] [Abstract][Full Text] [Related]
5. Cloning, expression and N-terminal formylation of ESAT-6 of Mycobacterium tuberculosis H37Rv.
Mir SA; Sharma S
Protein Expr Purif; 2013 Dec; 92(2):223-9. PubMed ID: 24056255
[TBL] [Abstract][Full Text] [Related]
6. Generation of Mycobacterium tuberculosis-specific recombinant antigens and evaluation of the clinical value of antibody detection for serological diagnosis of pulmonary tuberculosis.
Zhang X; Su Z; Zhang X; Hu C; Yu J; Gao Q; Wang H
Int J Mol Med; 2013 Mar; 31(3):751-7. PubMed ID: 23338746
[TBL] [Abstract][Full Text] [Related]
7. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy.
Mattos AM; Almeida Cde S; Franken KL; Alves CC; Abramo C; de Souza MA; L'Hotellier M; Alves MJ; Ferreira AP; Oliveira SC; Ottenhoff TH; Teixeira HC
Int Immunol; 2010 Sep; 22(9):775-82. PubMed ID: 20624776
[TBL] [Abstract][Full Text] [Related]
8. Expression and purification of Mycobacterium tuberculosis ESAT-6 and MPT64 fusion protein and its immunoprophylactic potential in mouse model.
Bai Y; Xue Y; Gao H; Wang L; Ding T; Bai W; Fan A; Zhang J; An Q; Xu Z
Protein Expr Purif; 2008 Jun; 59(2):189-96. PubMed ID: 18378164
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6.
Deng YH; He HY; Zhang BS
J Microbiol Immunol Infect; 2014 Feb; 47(1):48-56. PubMed ID: 23357605
[TBL] [Abstract][Full Text] [Related]
10. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
Majlessi L; Simsova M; Jarvis Z; Brodin P; Rojas MJ; Bauche C; Nouzé C; Ladant D; Cole ST; Sebo P; Leclerc C
Infect Immun; 2006 Apr; 74(4):2128-37. PubMed ID: 16552042
[TBL] [Abstract][Full Text] [Related]
11. [Preparation and application of recombinant Mycobacterium tuberculosis CFP10-ESAT-6 fusion protein].
Chen Q; Zhu DY; Luo XD; Jiang Y; Jiang S
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):244-8. PubMed ID: 15144615
[TBL] [Abstract][Full Text] [Related]
12. Attempted immunotherapy for Mycobacterium tuberculosis with viral and protein vaccines based on Ag85B-ESAT6 in a mouse model.
You Q; Jiang C; Kong W; Wu Y
Acta Microbiol Immunol Hung; 2012 Mar; 59(1):63-75. PubMed ID: 22510288
[TBL] [Abstract][Full Text] [Related]
13. Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guérin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice.
Wang LM; Shi CH; Fan XL; Xue Y; Bai YL; Xu ZK
Chin Med J (Engl); 2007 Jul; 120(14):1220-5. PubMed ID: 17697571
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and protective efficacy of novel Mycobacterium tuberculosis antigens.
Derrick SC; Yabe IM; Yang A; Kolibab K; Hollingsworth B; Kurtz SL; Morris S
Vaccine; 2013 Sep; 31(41):4641-6. PubMed ID: 23906890
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapeutic potential of n-terminally formylated ESAT-6 protein in murine tuberculosis.
Mir SA; Sharma S
Int J Mycobacteriol; 2022; 11(1):108-112. PubMed ID: 35295032
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus core particles displaying Mycobacterium tuberculosis antigen ESAT-6 enhance ESAT-6-specific immune responses.
Yin Y; Li H; Wu S; Dong D; Zhang J; Fu L; Xu J; Chen W
Vaccine; 2011 Aug; 29(34):5645-51. PubMed ID: 21689705
[TBL] [Abstract][Full Text] [Related]
17. Improved cellular immune response elicited by a ubiquitin-fused ESAT-6 DNA vaccine against Mycobacterium tuberculosis.
Wang QM; Kang L; Wang XH
Microbiol Immunol; 2009 Jul; 53(7):384-90. PubMed ID: 19563397
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of immunogenicity and protective efficacy against Mycobacterium tuberculosis infection elicited by recombinant Mycobacterium bovis BCG expressing human Interleukin-12p70 and Early Secretory Antigen Target-6 fusion protein.
Deng Y; Bao L; Yang X
Microbiol Immunol; 2011 Nov; 55(11):798-808. PubMed ID: 21831202
[TBL] [Abstract][Full Text] [Related]
19. Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein.
Stukova MA; Sereinig S; Zabolotnyh NV; Ferko B; Kittel C; Romanova J; Vinogradova TI; Katinger H; Kiselev OI; Egorov A
Tuberculosis (Edinb); 2006; 86(3-4):236-46. PubMed ID: 16677861
[TBL] [Abstract][Full Text] [Related]
20. [Molecular cloning, purification, and serological characterization of four specific antigens of Mycobacterium tuberculosis].
Xu L; Li HY; Ma LH
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Mar; 27(3):188-90. PubMed ID: 15130331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
